Literature DB >> 23467735

Plasma Vitamin D Levels And Vitamin D Receptor Polymorphisms Are Associated with Survival of Non-small Cell Lung Cancer.

Yao Liu1, Wei Chen, Zhi-Bin Hu, Lin Xu, Yong-Qian Shu, Shi-Yang Pan, Jun-Cheng Dai, Guang-Fu Jin, Hong-Xia Ma, Hong-Bing Shen.   

Abstract

OBJECTIVE: Vitamin D and its receptor (VDR) involve in multiple cellular processes and play an important role in the initiation and progression of malignancy. Thus we hypothesized that plasma vitamin D levels and single nucleotide polymorphisms (SNPs) in VDR may be of prognostic significance in non-small cell lung cancer (NSCLC).
METHODS: We examined plasma 25-hydroxyvitamin D [25(OH)D] levels in 87 patients diagnosed with NSCLC using enzyme-linked immunosorbent assay (ELISA) and genotyped seven potentially functional SNPs in VDR in 568 NSCLC patients on Illumina Golden Gate platform.
RESULTS: Patients with higher plasma 25(OH)D levels had worse survival than patients with lower ones (P for trend = 0.048). The SNPs of rs1544410 and rs739837 were independently associated with NSCLC survival (adjusted HR = 1.61, 95% CIs = 1.06-2.45 for rs739837 AA vs AC/CC and adjusted HR = 1.51, 95% CIs = 1.06-2.16 for rs1544410 AG/AA vs GG). A joint effect was observed between rs1544410 and rs739837 and the risk of death elevated as the number of unfavourable genotypes patients carried increased (P for trend = 0.003). There were no significant associations between VDR polymorphisms and plasma 25(OH)D levels.
CONCLUSION: Our findings indicate that plasma 25(OH)D levels and genetic variants of VDR may serve as prognostic markers for NSCLC in this Chinese population.

Entities:  

Keywords:  Chinese population; Non-small cell lung cancer; Prognosis; Vitamin D receptor polymorphisms

Year:  2011        PMID: 23467735      PMCID: PMC3587536          DOI: 10.1007/s11670-011-0033-3

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  22 in total

1.  A human skin equivalent model that mimics the photoproduction of vitamin D3 in human skin.

Authors:  E T Obi-Tabot; X Q Tian; T C Chen; M F Holick
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-03       Impact factor: 2.416

Review 2.  MicroRNAs: genomics, biogenesis, mechanism, and function.

Authors:  David P Bartel
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

3.  Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.

Authors:  Wei Zhou; Rebecca S Heist; Geoffrey Liu; Donna S Neuberg; Kofi Asomaning; Li Su; John C Wain; Thomas J Lynch; Edward Giovannucci; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-11       Impact factor: 4.254

Review 4.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

5.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

6.  Combinational effects of vitamin D3 and retinoic acid (all trans and 9 cis) on proliferation, differentiation, and programmed cell death in two small cell lung carcinoma cell lines.

Authors:  M Güzey; C Sattler; H F DeLuca
Journal:  Biochem Biophys Res Commun       Date:  1998-08-28       Impact factor: 3.575

7.  Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group.

Authors:  A C Lundin; P Söderkvist; B Eriksson; M Bergman-Jungeström; S Wingren
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

8.  Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.

Authors:  Shu-Pin Huang; Chao-Yuan Huang; Wen-Jeng Wu; Yeong-Shiau Pu; Jun Chen; Yun-Yun Chen; Chia-Cheng Yu; Tony T Wu; Jyh-Seng Wang; Ying-Huei Lee; Jong-Khing Huang; Chun-Hsiung Huang; Ming-Tsang Wu
Journal:  Int J Cancer       Date:  2006-10-15       Impact factor: 7.396

9.  Nuclear vitamin D receptor expression is associated with improved survival in non-small cell lung cancer.

Authors:  Malini Srinivasan; Anil V Parwani; Pamela A Hershberger; Diana E Lenzner; Joel L Weissfeld
Journal:  J Steroid Biochem Mol Biol       Date:  2010-10-16       Impact factor: 4.292

Review 10.  Genetics and biology of vitamin D receptor polymorphisms.

Authors:  André G Uitterlinden; Yue Fang; Joyce B J Van Meurs; Huibert A P Pols; Johannes P T M Van Leeuwen
Journal:  Gene       Date:  2004-09-01       Impact factor: 3.688

View more
  11 in total

1.  Serum vitamin D, vitamin D binding protein, and lung cancer survival.

Authors:  Gabriella M Anic; Stephanie J Weinstein; Alison M Mondul; Satu Männistö; Demetrius Albanes
Journal:  Lung Cancer       Date:  2014-10-20       Impact factor: 5.705

Review 2.  Vitamin D and Cancer Risk and Mortality: State of the Science, Gaps, and Challenges.

Authors:  Alison M Mondul; Stephanie J Weinstein; Tracy M Layne; Demetrius Albanes
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

3.  Role of vitamin D receptor gene polymorphisms in pancreatic cancer: a case-control study in China.

Authors:  Lei Li; Feifei Shang; Weihui Zhang; Canhong Zhang; Junshan Li; Changhui Wang; Lin Wei
Journal:  Tumour Biol       Date:  2015-01-24

4.  Genetic variations in vitamin D receptor were associated with the outcomes of hepatitis C virus infection among Chinese population.

Authors:  Meng-ping Wu; Jin-wei Zhang; Peng Huang; Ya-ping Han; Yun Zhang; Zhi-hang Peng; Jie Wang; Ping Zhu; Jing Su; Rong-bin Yu; Jun Li; Ming Yue
Journal:  J Hum Genet       Date:  2015-10-08       Impact factor: 3.172

5.  Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.

Authors:  Qianqian Feng; Han Zhang; Zhengqin Dong; Yang Zhou; Jingping Ma
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 6.  The impact of vitamin D pathway genetic variation and circulating 25-hydroxyvitamin D on cancer outcome: systematic review and meta-analysis.

Authors:  P G Vaughan-Shaw; F O'Sullivan; S M Farrington; E Theodoratou; H Campbell; M G Dunlop; L Zgaga
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

7.  The relationship between circulating 25-hydroxyvitamin D and survival in newly diagnosed advanced non-small-cell lung cancer.

Authors:  Pankaj G Vashi; Persis Edwin; Brenten Popiel; Digant Gupta
Journal:  BMC Cancer       Date:  2015-12-24       Impact factor: 4.430

8.  Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk.

Authors:  Xiayu Wu; Jiaoni Cheng; Kaiyun Yang
Journal:  Int J Mol Sci       Date:  2016-09-22       Impact factor: 5.923

9.  Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes.

Authors:  Jian Liu; Yongquan Dong; Chao Lu; Yina Wang; Ling Peng; Mengjie Jiang; Yemin Tang; Qiong Zhao
Journal:  Oncotarget       Date:  2017-06-28

Review 10.  Single Nucleotide Polymorphisms in 25-Hydroxyvitamin D3 1-Alpha-Hydroxylase (CYP27B1) Gene: The Risk of Malignant Tumors and Other Chronic Diseases.

Authors:  Maria Latacz; Jadwiga Snarska; Elżbieta Kostyra; Ewa Fiedorowicz; Huub Fj Savelkoul; Roman Grzybowski; Anna Cieślińska
Journal:  Nutrients       Date:  2020-03-18       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.